Bioactive Principles from Panamanian Medicinal Plants
Total Page:16
File Type:pdf, Size:1020Kb
BIOACTIVE PRINCIPLES FROM PANAMANIAN MEDICINAL PLANTS Thesis presented by Pablo Narclso Solis Gonzalez for the degree of Doctor of Philosophy In the Faculty of Medicine of the University of London Department of Pharmacognosy The School of Pharmacy University of London 1994 ProQuest Number: 10105140 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10105140 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 A tribute to my Grand Parents, Pablo and Conce and to my Parents, Nato and Gladys my models of fortitude. ABSTRACT Plants are widely used in Panama and Central America to cure different diseases, including malaria and amoebic dysentery. Cephaëlis ipecacuanha of the famiiy Rubiaceae contains emetine, which is used in the treatment of severe amoebic dysentery. Species of Rubiaceae, Simaroubaceae, Meliaceae and Menispermaceae have been examined, they are known to contain isoquinoline alkaloids, quassinoids, limonoids and bisbenzylisoquinoline (bbiq) alkaloids, respectively, with activity against Plasmodium falciparum. In order to obtain antiprotozoal natural products such as quassinoids, limonoids, bbiq’s and emetine reiated alkaloids it was decided to investigate the following plants: Guarea macropetaia, G. rhopalocarpa, Ruagea glabra (Meliaceae); Abuta dwyerana (Menispermaceae); Cephaëlis camponutans, 0. dichroa, 0. dimorphandrloldes, 0. glomerulata, Laslanthus panamensis (Rubiaceae); PIcramnIa antldesma subsp. fessonia, P. teapensis (Simaroubaceae). Extracts from different parts of the plants were fractionated and tested against brine shrimp and KB ceils. Four plants were chemically studied and the isoiated compounds were characterized by mass spectra, infrared, ultraviolet, and NMR, also, two dimensional NMR experiments such as COSY-45, HMQC, HMBC and ROESY. Circular dichroism was used to establish the absolute configuration of some of the compounds. C. camponutans yielded benz[g]isoquinoline-5,10-dione, isolated for the first time from the plant kingdom, and a the new 1-OH- benzoisochromanquinone. Both compounds showed activity against brine shrimp, KB ceils and Plasmodium falciparum, in vitro. C. dichroa yielded six indole monoterpenoid aikaloids, including strictosidine, strictosamide, angustine, vallesiachotamine, iso-vallesiachotamine and the novel vallesiachotamine lactone. In contrast, 0. glomerulata yielded three new quinoline alkaloids. named, glomerulatine A, B and C. The taxonomic position of Cephaëlis is unclear and more detailed information on the constituent alkaloids may prove valuable in unravelling this problem. The butanolic fraction from de leaves of P. antldesma subsp. fessonia, showed strong activity against KB cells and yielded two known anthraquinones (aloe-emodin, aloe-emodinanthrone) and three new C-glycoside of aloe-emodin, named picramnioside A, B and C. The C-glycosides showed activity against KB cells. A cytotoxic microwell test using Anemia salina (brine shrimp) was developed in order to overcome some of the disadvantages of the previously described method. The test was predictive of cytotoxicity and compounds with activity on the nervous system were inactive. The activity of the quassinoids against KB cell and P. falciparum parallel the activity against brine shrimp. ACKNOWLEDGEMENTS I would like to thank my supervisor Professor J. David Phillipson for his precious help and friendship without which this work would not have been possible. I am also indebted to Professor Mahabir P. Gupta, Departamento de Quimica Medicinal y Farmacognosia, Facultad de Farmacia, Universidad de Panama for his encouragement and guidance. I would like to express my appreciation and thanks to Professors Don Antonio Gonzalez and Don Angel Gutierrez Ravelo and colleagues in the Institute de Productos Maturates Organicos, Universidad de La Laguna, Tenerife, Spain, where part of this work was carried out. Also, I am indebted to Professor Mireya Correa and Mrs Carmen Galdames for their valuable help in collection, identification and plant preparation. I am grateful to Mr. Rutilio Paredes, Research Coordinator of Program of Ecology and Management of Wild Areas of Kuna Yala (PEMASKY), who very kindly allowed access for plant collection. I thank Mrs. J. Hawkes for running the NMR experiments in the AMX400 and WM250 NMR, University of London Intercollegiate Research Service at King’s College and Dr. K. Welham and his colleagues for running the mass spectra at the Mass Spectrometry Unit at The School of Pharmacy, University of London. I am grateful to my colleges in the Department of Pharmacognosy, The School of Pharmacy with whom I have collaborated in various aspects of this work, particularly Miss Maria Camacho, Miss Caroline Lang’at and Dr. Colin Wright. I also wish to thank Drs. D.C. Warhurst and G.C. Kirby, Department of Medical Parasitology, The London School of Hygiene and Tropical Medicine for running the antimalarial activity of some of the isolated compounds. I am grateful to Dr. R.T. Brown, University of Manchester for generous gifts of strictosidine, vincosidine and their acetylated derivatives and for their NMR spectra. Also, I would like to thank Mrs. M. Pickett for technical help and Mrs A. Cavanagh for excellent graphical work in the preparation on slides and posters for use at conferences. Undoubtedly, I am eternally indebted to my wife and lover, Nilka, and my children, Nilkita, Pablito and Paola, for their daily encouragement, comprehension and patience during these three difficult years of my life. I am grateful to the Commission of the European Community for the provision of a research scholarship (B/CI1*-913064). CONTENTS Page Abstract 3 Acknowledgement 5 List of Abbreviations 12 List of Figures 15 List of Tables 16 SECTION 1 INTRODUCTION 18 1.1 Health care in Panama 19 1.1.1 The country 19 1.1.2 Treatment of diseases 20 1.1.2.1 Health care coverage in Panama 20 1.1.2.2 Major health problems in Panama 21 1.1.3 Ethnomedicine in Panama 25 1.1.4 Natural resources and conservation 28 1.2 Selection of plants for chemical and biological investigation 36 1.2.1 Traditional medicine 36 1.2.2 Random selection of plants for chemical investigation 38 1.2.3 Chemotaxonomy 39 1.2.3.1 Chemotaxonomy background 41 1.3 Biological testing of plant extracts 42 1.3.1 Advantages and disadvantages of in-vivo and in-vitro testing 43 1.3.2 Simple bioassays 45 1.3.2.1 Brine shrimp assay 45 1.3.2.2 KB cells assay 46 1.3.2.3 P. falciparum assay 47 1.4 Aims of this study 49 SECTION 2. PLANTS SELECTED FOR INVESTIGATION 50 2.1 Meliaceous plants 51 2.2 Menispermaceous plants 57 2.3 Rubiaceous plants 58 2.4 Simaroubaceous plants 67 SECTION 3 TESTING FOR BIOLOGICAL ACTIVITY 72 3.1 Materials and methods 73 3.1.1 New microwell brine shrimp assay 73 3.1.2 Brine shrimp assay 74 3.1.3 KB cells assay 74 3.1.4 P. falciparumàssay 76 3.2 Results and discussion 76 3.2.1 Evaluation of brine shrimp assay 76 3.2.2 Activity of the plant crude extracts against brine shrimp and KB cells 80 SECTION 4 PHYTOCHEMISTRY 89 4.1 Material and general methods 90 4.1.1 Plant material 90 4.1.2 Solvents 90 4.1.3 Chromatography techniques 92 4.1.4 Spectrometric methods 92 4.1.4.1 Ultraviolet spectroscopy (U V ) 92 4.1.4.2 Infrared spectroscopy (IR ) 92 4.1.4.3 Mass spectrometry (M S) 93 4.1.4.4 Nuclear magnetic resonance (N M R ) 93 4.1.4.5 Polarimetry 93 4.1.4.6 Circular dichroism (CD) 94 4.1.5 Preparation of acetyl derivatives 94 4.2.1 Preparation of crude plant extracts for biological test 94 8 4.2.1.1 Results 94 4.3 Isolation and identification of bioactive compounds from Cephaëlis camponutans {Psychotria camponutans) 98 4.3.1 Extraction procedure 98 4.3.2 Identification of the isolated compounds 98 4.3.3.1 1 -Hydroxybenzoisochromanquinone 98 4.3.3.1.1 Spectral data 98 4.3.3.1.2 1 - Acety Ibenzoisochromanquinone 99 4.3.3.1.2.1 Spectral data 99 4.3.3.2 Benz[g]isoquinoline-5J0 dione 99 4.3.3.2.1 Spectral data 99 4.3.4 Discussion 1 0 2 4.3.5 Biological activity of the isolates 108 4.3.5.1 Results and discussion 108 4.4 Isolation of alkaloids fromCephaëlis dichroa 1 1 0 4.4.1 Extraction and separation procedure 1 1 0 4.4.2 Identification of isolated compounds 1 1 0 4.4.2.1 Vallesiachotamine lactone 1 1 0 4.4.2.1.1 Spectral data 1 1 0 4.4.2.2 Vallesiachotamine 1 1 1 4.4.2.2.1 Spectral data 1 1 1 4.4.2.3 Strictosidine 1 1 2 4.4.2.3.1 Spectral data 1 1 2 4.4.2.4 Strictosidine lactam 113 4.4.2.4.1 Spectral data 113 4.4.2.4.2 Acetyl strictosidine lactam 114 4.4.2.4.2.1 Spectral data 114 4.4.2.5 Angustine 115 4.4.2.5.1 Spectral data 115 4.4.3 Discussion 117 4.5 Isolation and identification of alkaloids from Cephaëlis glomerulata (Psychotria glomerulata) 121 4.5.1 Extraction and separation procedure 121 4.5.2 Identification of the isolated compounds 121 4.5.2.1 Glomerulatine A 121 4.5.2.